Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2011 | 895 Thousand USD | -9.41% |
| 2010 | 988 Thousand USD | -1.79% |
| 2009 | 1 Million USD | -20.1% |
| 2008 | 1.25 Million USD | -42.09% |
| 2007 | 2.17 Million USD | 12.53% |
| 2006 | 1.93 Million USD | 13.51% |
| 2005 | 1.7 Million USD | -27.91% |
| 2004 | 2.36 Million USD | -19.2% |
| 2003 | 2.92 Million USD | -44.75% |
| 2002 | 5.28 Million USD | -58.16% |
| 2001 | 12.64 Million USD | 17.9% |
| 2000 | 10.72 Million USD | 62.47% |
| 1999 | 6.6 Million USD | 200.0% |
| 1998 | 2.2 Million USD | -12.0% |
| 1997 | 2.5 Million USD | -40.48% |
| 1996 | 4.2 Million USD | 366.67% |
| 1995 | 900 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2011 FY | 895 Thousand USD | -9.41% |
| 2010 FY | 988 Thousand USD | -1.79% |
| 2009 FY | 1 Million USD | -20.1% |
| 2009 Q1 | 1.16 Million USD | -7.39% |
| 2008 Q2 | 1.61 Million USD | -8.92% |
| 2008 Q3 | 1.61 Million USD | 0.25% |
| 2008 Q4 | 1.25 Million USD | -22.19% |
| 2008 Q1 | 1.77 Million USD | -18.49% |
| 2008 FY | 1.25 Million USD | -42.09% |
| 2007 Q3 | 2.16 Million USD | -6.67% |
| 2007 Q1 | 1.77 Million USD | -8.18% |
| 2007 Q2 | 2.32 Million USD | 30.95% |
| 2007 Q4 | 2.17 Million USD | 0.28% |
| 2007 FY | 2.17 Million USD | 12.53% |
| 2006 FY | 1.93 Million USD | 13.51% |
| 2006 Q1 | 1.96 Million USD | 15.16% |
| 2006 Q2 | 2.27 Million USD | 16.07% |
| 2006 Q4 | 1.93 Million USD | 4.32% |
| 2006 Q3 | 1.85 Million USD | -18.59% |
| 2005 Q3 | 3.19 Million USD | -7.53% |
| 2005 FY | 1.7 Million USD | -27.91% |
| 2005 Q1 | 2.15 Million USD | -8.6% |
| 2005 Q2 | 3.45 Million USD | 59.92% |
| 2005 Q4 | 1.7 Million USD | -46.66% |
| 2004 Q2 | 2.24 Million USD | -13.74% |
| 2004 FY | 2.36 Million USD | -19.2% |
| 2004 Q4 | 2.36 Million USD | -8.7% |
| 2004 Q1 | 2.59 Million USD | -11.09% |
| 2004 Q3 | 2.58 Million USD | 15.39% |
| 2003 Q4 | 2.92 Million USD | -28.05% |
| 2003 FY | 2.92 Million USD | -44.75% |
| 2003 Q3 | 4.06 Million USD | -2.73% |
| 2003 Q1 | 4.74 Million USD | -10.3% |
| 2003 Q2 | 4.17 Million USD | -11.99% |
| 2002 FY | 5.28 Million USD | -58.16% |
| 2002 Q4 | 5.28 Million USD | -46.73% |
| 2002 Q3 | 9.92 Million USD | -9.25% |
| 2002 Q2 | 10.94 Million USD | -11.22% |
| 2002 Q1 | 12.32 Million USD | -2.52% |
| 2001 Q1 | 9.37 Million USD | -12.55% |
| 2001 FY | 12.64 Million USD | 17.9% |
| 2001 Q4 | 12.64 Million USD | 2.19% |
| 2001 Q3 | 12.37 Million USD | 6.22% |
| 2001 Q2 | 11.64 Million USD | 24.21% |
| 2000 Q2 | 12.1 Million USD | 20.63% |
| 2000 Q3 | 12.84 Million USD | 6.1% |
| 2000 Q4 | 10.72 Million USD | -16.52% |
| 2000 Q1 | 10.03 Million USD | 52.06% |
| 2000 FY | 10.72 Million USD | 62.47% |
| 1999 Q3 | 3.3 Million USD | -25.0% |
| 1999 Q4 | 6.6 Million USD | 100.0% |
| 1999 FY | 6.6 Million USD | 200.0% |
| 1999 Q1 | 3.3 Million USD | 50.0% |
| 1999 Q2 | 4.4 Million USD | 33.33% |
| 1998 Q2 | 3.3 Million USD | -2.94% |
| 1998 Q1 | 3.4 Million USD | 36.0% |
| 1998 FY | 2.2 Million USD | -12.0% |
| 1998 Q4 | 2.2 Million USD | -26.67% |
| 1998 Q3 | 3 Million USD | -9.09% |
| 1997 Q4 | 2.5 Million USD | 31.58% |
| 1997 Q2 | 3.9 Million USD | -17.02% |
| 1997 FY | 2.5 Million USD | -40.48% |
| 1997 Q3 | 1.9 Million USD | -51.28% |
| 1997 Q1 | 4.7 Million USD | 27.03% |
| 1996 Q3 | 4.2 Million USD | 320.0% |
| 1996 Q2 | 1 Million USD | 0.0% |
| 1996 FY | 4.2 Million USD | 366.67% |
| 1996 Q4 | 3.7 Million USD | -11.9% |
| 1995 FY | 900 Thousand USD | 0.0% |
| 1995 Q3 | 900 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 51.307% |
| Ansell Limited | 3.23 Billion USD | 99.972% |
| Ansell Limited | 3.24 Billion USD | 99.972% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | 99.817% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -197.974% |
| Psykey, Inc. | 1.72 Million USD | 48.187% |
| ConvaTec Group Plc | 3.7 Billion USD | 99.976% |
| ConvaTec Group Plc | 3.71 Billion USD | 99.976% |
| Encision Inc. | 3.81 Million USD | 76.514% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -37.295% |
| LifePoint, Inc. | 8.8 Million USD | 89.84% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 94.391% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | 83.695% |
| Reflect Scientific, Inc. | 2.66 Million USD | 66.466% |
| SmileDirectClub, Inc. | 597.06 Million USD | 99.85% |
| Sector 10, Inc. | 1000.00 USD | -89400.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.981% |
| SheerVision, Inc. | 837.56 Thousand USD | -6.857% |
| United Health Products, Inc. | 284.64 Thousand USD | -214.429% |
| Vasamed, Inc. | 1.6 Million USD | 44.071% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -301.034% |
| Yubo International Biotech Limited | 2.34 Million USD | 61.891% |